Literature DB >> 24919048

Epidemiological features of esophageal cancer. Squamous cell carcinoma versus adenocarcinoma.

Maria Aparecida Coelho de Arruda Henry1, Mauro Masson Lerco2, Priscila Watson Ribeiro3, Maria Aparecida Marchesan Rodrigues4.   

Abstract

PURPOSE: To analyze the epidemiological features of patients with esophageal cancer according to the histopathological types: squamous cell carcinoma or adenocarcinoma.
METHODS: A total of 100 patients with esophageal cancer, being 50 squamous cell carcinomas and 50 adenocarcinomas were analyzed for demographics, nutritional factors, lifestyle habits, benign pathological conditions associated, like Barrett's esophagus and megaesophagus, tumor stage and survival rates. The nutritional factors evaluated included body mass index, percent weight loss, hemoglobin and albumin serum levels.
RESULTS: Esophageal cancer occurred more often in men over 50 years-old in both histological groups. No significant differences on age and gender were found between the histological groups. Squamous cell carcinoma was significantly more frequent in blacks than adenocarcinoma. Alcohol consumption and smoking were significantly associated with squamous cell carcinoma. Higher values of body mass index were seen in patients with adenocarcinoma. Barrett's esophagus was found in nine patients (18%) with adenocarcinoma, and megaesophagus in two patients (4%) with squamous cell carcinoma. The majority of patients were on stages III and IV in both histological groups. The mean survival rates were 7.7 ± 9.5 months for patients with squamous cell carcinoma and 8.0 ± 10.9 months for patients with adenocarcinoma. No significant differences on tumor stage and survival rates were detected between the histological groups.
CONCLUSION: Epidemiological features are distinct for the histopathological types of esophageal cancer. Squamous cell carcinoma is associated with black race, alcohol and smoking, while adenocarcinoma is related to higher body mass index, white race and Barrett's esophagus.

Entities:  

Mesh:

Year:  2014        PMID: 24919048     DOI: 10.1590/s0102-86502014000600007

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  11 in total

1.  Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.

Authors:  Mimi C Tan; Nabil Mansour; Donna L White; Amy Sisson; Hashem B El-Serag; Aaron P Thrift
Journal:  Aliment Pharmacol Ther       Date:  2020-05-26       Impact factor: 8.171

2.  ENDOSCOPIC TREATMENT OF ESOPHAGEAL NEOPLASIA: A DECADE OF EVOLUTION.

Authors:  Nicholas J Shaheen
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

3.  L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.

Authors:  Jin-Cheng Guo; Yang-Min Xie; Li-Qiang Ran; Hui-Hui Cao; Chun Sun; Jian-Yi Wu; Zhi-Yong Wu; Lian-Di Liao; Wei-Jiang Zhao; Wang-Kai Fang; En-Min Li; Li-Yan Xu; Melitta Schachner; Jian-Jun Xie
Journal:  J Mol Med (Berl)       Date:  2017-09-22       Impact factor: 4.599

4.  B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.

Authors:  Xinran Chen; Ling Wang; Wei Wang; Lianmei Zhao; Baoen Shan
Journal:  Cancer Sci       Date:  2016-05-27       Impact factor: 6.716

5.  Increased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in mice.

Authors:  Xinran Chen; Wei Wang; Hongwei Man; Pengfei Li; Baoen Shan
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

6.  The long-term spatial-temporal trends and burden of esophageal cancer in one high-risk area: A population-registered study in Feicheng, China.

Authors:  Xiubin Sun; Deli Zhao; Yi Liu; Yunxia Liu; Zhongshang Yuan; Jialin Wang; Fuzhong Xue
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

7.  Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.

Authors:  Xuan Sun; Robert C G Martin; Qianqian Zheng; Russell Farmer; Harshul Pandit; Xuanyi Li; Kevin Jacob; Jian Suo; Yan Li
Journal:  Cell Oncol (Dordr)       Date:  2018-08-16       Impact factor: 6.730

8.  Adult height, body mass index change, and body shape change in relation to esophageal squamous cell carcinoma risk: A population-based case-control study in China.

Authors:  Xiaorong Yang; Tongchao Zhang; Xiaolin Yin; Ziyu Yuan; Hui Chen; Amelie Plymoth; Li Jin; Xingdong Chen; Ming Lu; Weimin Ye
Journal:  Cancer Med       Date:  2019-08-01       Impact factor: 4.452

9.  Interaction of XRCC1 Arg399Gln Polymorphism and Alcohol Consumption Influences Susceptibility of Esophageal Cancer.

Authors:  Man Li; Xia Yu; Zhi-Yan Zhang; Chun-Long Wu; Hai-Long Xu
Journal:  Gastroenterol Res Pract       Date:  2016-02-01       Impact factor: 2.260

10.  Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.

Authors:  Dong-Bin Wang; Zhong-Yi Sun; Li-Min Deng; De-Qing Zhu; Hong-Gang Xia; Peng-Zhi Zhu
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.